Podcast Episodes

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Season 25 Episode 20

Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. 

CME inform…

Published on 5 months, 1 week ago

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Season 25 Episode 19

Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer. 

CME info…

Published on 5 months, 3 weeks ago

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Season 25 Episode 18

Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the …

Published on 6 months ago

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Season 25 Episode 17

Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lu…

Published on 6 months, 2 weeks ago

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Season 25 Episode 16

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. 

CME information…

Published on 6 months, 2 weeks ago

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Season 25 Episode 15

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.  

CME information and select publications here.

Published on 6 months, 2 weeks ago

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Season 25 Episode 14

Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer. 

CME information and select publications here.

Published on 6 months, 4 weeks ago

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates

Season 25 Episode 13

Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management of breast cancer. 

CME information and select publ…

Published on 7 months ago

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel

Season 25 Episode 12

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associat…

Published on 7 months, 1 week ago

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy

Season 25 Episode 11

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-po…

Published on 7 months, 1 week ago